Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 1 to 50 of 807

1.

Osteopontin and Disease Activity in Patients with Recent-onset Systemic Lupus Erythematosus: Results from the SLICC Inception Cohort.

Wirestam L, Enocsson H, Skogh T, Padyukov L, Jönsen A, Urowitz MB, Gladman DD, Romero-Diaz J, Bae SC, Fortin PR, Sanchez-Guerrero J, Clarke AE, Bernatsky S, Gordon C, Hanly JG, Wallace D, Isenberg DA, Rahman A, Merrill J, Ginzler E, Alarcón GS, Chatham WW, Petri M, Khamashta M, Aranow C, Mackay M, Dooley MA, Manzi S, Ramsey-Goldman R, Nived O, Steinsson K, Zoma A, Ruiz-Irastorza G, Lim S, Kalunian K, Inanc M, Vollenhoven RV, Ramos-Casals M, Kamen DL, Jacobsen S, Peschken C, Askanase A, Stoll T, Bruce IN, Wetterö J, Sjöwall C.

J Rheumatol. 2019 Jan 15. pii: jrheum.180713. doi: 10.3899/jrheum.180713. [Epub ahead of print]

2.

Enhanced Electric Dipole Strength for the Weakly Bound States in ^{27}Ne.

Loelius C, Kobayashi N, Iwasaki H, Bazin D, Belarge J, Bender PC, Brown BA, Elder R, Elman B, Gade A, Grinder M, Heil S, Hufnagel A, Longfellow B, Lunderberg E, Mathy M, Otsuka T, Petri M, Syndikus I, Tsunoda N, Weisshaar D, Whitmore K.

Phys Rev Lett. 2018 Dec 28;121(26):262501. doi: 10.1103/PhysRevLett.121.262501.

PMID:
30636164
3.

Association between changes in gene signatures expression and disease activity among patients with systemic lupus erythematosus.

Petri M, Fu W, Ranger A, Allaire N, Cullen P, Magder LS, Zhang Y.

BMC Med Genomics. 2019 Jan 9;12(1):4. doi: 10.1186/s12920-018-0468-1.

4.

Resolution of Inflammation Through the Lipoxin and ALX/FPR2 Receptor Pathway Protects Against Abdominal Aortic Aneurysms.

Petri MH, Thul S, Andonova T, Lindquist-Liljeqvist M, Jin H, Skenteris NT, Arnardottir H, Maegdefessel L, Caidahl K, Perretti M, Roy J, Bäck M.

JACC Basic Transl Sci. 2018 Dec 31;3(6):719-727. doi: 10.1016/j.jacbts.2018.08.005. eCollection 2018 Dec.

5.

Low aspirin use and high prevalence of pre-eclampsia risk factors among pregnant women in a multinational SLE inception cohort.

Mendel A, Bernatsky SB, Hanly JG, Urowitz MB, Clarke AE, Romero-Diaz J, Gordon C, Bae SC, Wallace DJ, Merrill JT, Buyon JP, Isenberg DA, Rahman A, Ginzler EM, Petri M, Dooley MA, Fortin PR, Gladman DD, Steinsson K, Ramsey-Goldman R, Khamashta MA, Aranow C, Mackay M, Alarcón GS, Manzi S, Nived O, Jönsen A, Zoma AA, van Vollenhoven RF, Ramos-Casals M, Ruiz-Irastorza G, Lim S, Kalunian KC, Inanc M, Kamen DL, Peschken CA, Jacobsen S, Askanase A, Sanchez-Guerrero J, Bruce IN, Costedoat-Chalumeau N, Vinet É.

Ann Rheum Dis. 2018 Dec 20. pii: annrheumdis-2018-214434. doi: 10.1136/annrheumdis-2018-214434. [Epub ahead of print] No abstract available.

6.

Predictors of persistent disease activity and long quiescence in systemic lupus erythematosus: results from the Hopkins Lupus Cohort.

Giannakou I, Chatzidionysiou K, Magder LS, Györi N, van Vollenhoven R, Petri MA.

Lupus Sci Med. 2018 Nov 2;5(1):e000287. doi: 10.1136/lupus-2018-000287. eCollection 2018.

7.

Systemic lupus erythematosus: Diagnosis and clinical management.

Fava A, Petri M.

J Autoimmun. 2019 Jan;96:1-13. doi: 10.1016/j.jaut.2018.11.001. Epub 2018 Nov 16. Review.

PMID:
30448290
8.

Psychosis in Systemic Lupus Erythematosus: Results From an International Inception Cohort Study.

Hanly JG, Li Q, Su L, Urowitz MB, Gordon C, Bae SC, Romero-Diaz J, Sanchez-Guerrero J, Bernatsky S, Clarke AE, Wallace DJ, Isenberg DA, Rahman A, Merrill JT, Fortin PR, Gladman DD, Bruce IN, Petri M, Ginzler EM, Dooley MA, Steinsson K, Ramsey-Goldman R, Zoma AA, Manzi S, Nived O, Jonsen A, Khamashta MA, Alarcón GS, van Vollenhoven RF, Aranow C, Mackay M, Ruiz-Irastorza G, Ramos-Casals M, Lim SS, Inanc M, Kalunian KC, Jacobsen S, Peschken CA, Kamen DL, Askanase A, Theriault C, Farewell V.

Arthritis Rheumatol. 2018 Oct 30. doi: 10.1002/art.40764. [Epub ahead of print]

PMID:
30375754
9.

Enhancer RNA and NFκB-dependent P300 regulation of ADAMDEC1.

Shi L, Li S, Maurer K, Zhang Z, Petri M, Sullivan KE.

Mol Immunol. 2018 Nov;103:312-321. doi: 10.1016/j.molimm.2018.09.019. Epub 2018 Oct 20.

PMID:
30352365
10.

Distinct Effector B Cells Induced by Unregulated Toll-like Receptor 7 Contribute to Pathogenic Responses in Systemic Lupus Erythematosus.

Jenks SA, Cashman KS, Zumaquero E, Marigorta UM, Patel AV, Wang X, Tomar D, Woodruff MC, Simon Z, Bugrovsky R, Blalock EL, Scharer CD, Tipton CM, Wei C, Lim SS, Petri M, Niewold TB, Anolik JH, Gibson G, Lee FE, Boss JM, Lund FE, Sanz I.

Immunity. 2018 Oct 16;49(4):725-739.e6. doi: 10.1016/j.immuni.2018.08.015. Epub 2018 Oct 9.

PMID:
30314758
11.

New alcohol flushing in a patient with atopic dermatitis under therapy with dupilumab.

Herz S, Petri M, Sondermann W.

Dermatol Ther. 2018 Oct 4:e12762. doi: 10.1111/dth.12762. [Epub ahead of print] No abstract available.

PMID:
30288874
12.

Biomechanical properties of adjustable extracortical graft fixations in ACL reconstruction.

Ettinger M, Karkosch R, Horstmann H, Savov P, Calliess T, Smith T, Petri M; ESSKA under 45-committee (2016-2018).

J Exp Orthop. 2018 Sep 29;5(1):41. doi: 10.1186/s40634-018-0154-4.

13.

MICROPERIMETRY AS A SCREENING TEST FOR HYDROXYCHLOROQUINE RETINOPATHY: The Hard-Risk-1 Study.

Iftikhar M, Kaur R, Nefalar A, Usmani B, Kherani S, Rashid I, Schönbach E, Petri M, Scholl HPN, Shah SM.

Retina. 2018 Sep 17. doi: 10.1097/IAE.0000000000002313. [Epub ahead of print]

PMID:
30234854
14.

Establishing Surrogate Kidney Endpoints for Lupus Nephritis Clinical Trials: Development and Validation of a Novel Approach to Predict Future Kidney Outcomes.

Mackay M, Dall'Era M, Fishbein J, Kalunian K, Lesser M, Sanchez Guerrero J, Levy DM, Silverman E, Petri M, Arriens C, Lewis EJ, Korbet SM, Conti F, Tesar V, Hruskova Z, Borba EF, Bonfa E, Chan TM, Rathi M, Gupta KL, Jha V, Hasni S, West MR, Silverman E, Solomons N, Houssiau FA, Romera Diaz J, Mejia-Vilet J, Rovin BH.

Arthritis Rheumatol. 2018 Sep 17. doi: 10.1002/art.40724. [Epub ahead of print]

PMID:
30225865
15.

Factors associated with first thrombosis in patients presenting with obstetric antiphospholipid syndrome (APS) in the APS Alliance for Clinical Trials and International Networking Clinical Database and Repository: a retrospective study.

de Jesús GR, Sciascia S, Andrade D, Barbhaiya M, Tektonidou M, Banzato A, Pengo V, Ji L, Meroni PL, Ugarte A, Cohen H, Branch DW, Andreoli L, Belmont HM, Fortin PR, Petri M, Rodriguez E, Cervera R, Knight JS, Atsumi T, Willis R, Nascimento IS, Rosa R, Erkan D, Levy RA; APS ACTION.

BJOG. 2018 Sep 17. doi: 10.1111/1471-0528.15469. [Epub ahead of print]

PMID:
30222236
16.

Pauci-immune Glomerulonephritis in Systemic Lupus Erythematosus (SLE).

Liebowitz J, Fine D, Seo P, Petri M, Machireddy K, Haque U, Manno R, Timlin H.

Cureus. 2018 Jul 9;10(7):e2949. doi: 10.7759/cureus.2949.

17.

Biomechanical and histological analyses of the fracture healing process after direct or prolonged reduction.

Peterburs B, Mittelstaedt A, Haas P, Petri M, Westphal R, Dullin C, Sehmisch S, Neunaber C.

Eur J Med Res. 2018 Sep 4;23(1):39. doi: 10.1186/s40001-018-0337-6.

18.

Rheumatoid Pachymeningitis: A Rare Complication of Rheumatoid Arthritis.

Tiniakou E, Kontzialis M, Petri M.

J Rheumatol. 2018 Aug;45(9):1325-1326. doi: 10.3899/jrheum.171074. No abstract available.

PMID:
30173179
19.

Reply.

Petri M, Magder LS.

Arthritis Rheumatol. 2018 Dec;70(12):2099. doi: 10.1002/art.40693. Epub 2018 Sep 24. No abstract available.

PMID:
30120905
20.

Genetic fine mapping of systemic lupus erythematosus MHC associations in Europeans and African Americans.

Hanscombe KB, Morris DL, Noble JA, Dilthey AT, Tombleson P, Kaufman KM, Comeau M, Langefeld CD, Alarcon-Riquelme ME, Gaffney PM, Jacob CO, Sivils KL, Tsao BP, Alarcon GS, Brown EE, Croker J, Edberg J, Gilkeson G, James JA, Kamen DL, Kelly JA, McCune J, Merrill JT, Petri M, Ramsey-Goldman R, Reveille JD, Salmon JE, Scofield H, Utset T, Wallace DJ, Weisman MH, Kimberly RP, Harley JB, Lewis CM, Criswell LA, Vyse TJ.

Hum Mol Genet. 2018 Nov 1;27(21):3813-3824. doi: 10.1093/hmg/ddy280.

21.

A Prospective International Study on Adherence to Treatment in 305 Patients With Flaring SLE: Assessment by Drug Levels and Self-Administered Questionnaires.

Costedoat-Chalumeau N, Houssiau F, Izmirly P, Guern VL, Navarra S, Jolly M, Ruiz-Irastorza G, Baron G, Hachulla E, Agmon-Levin N, Shoenfeld Y, Dall'Ara F, Buyon J, Deligny C, Cervera R, Lazaro E, Bezanahary H, Leroux G, Morel N, Viallard JF, Pineau C, Galicier L, Vollenhoven RV, Tincani A, Nguyen H, Gondran G, Zahr N, Pouchot J, Piette JC, Petri M, Isenberg D.

Clin Pharmacol Ther. 2018 Aug 6. doi: 10.1002/cpt.1194. [Epub ahead of print]

PMID:
30079582
22.

Antinuclear Antibody-Negative Systemic Lupus Erythematosus in an International Inception Cohort.

Choi MY, Clarke AE, St Pierre Y, Hanly JG, Urowitz MB, Romero-Diaz J, Gordon C, Bae SC, Bernatsky S, Wallace DJ, Merrill JT, Isenberg DA, Rahman A, Ginzler EM, Petri M, Bruce IN, Dooley MA, Fortin PR, Gladman DD, Sanchez-Guerrero J, Steinsson K, Ramsey-Goldman R, Khamashta MA, Aranow C, Alarcón GS, Manzi S, Nived O, Zoma AA, van Vollenhoven RF, Ramos-Casals M, Ruiz-Irastorza G, Lim SS, Kalunian KC, Inanc M, Kamen DL, Peschken CA, Jacobsen S, Askanase A, Stoll T, Buyon J, Mahler M, Fritzler MJ.

Arthritis Care Res (Hoboken). 2018 Jul 25. doi: 10.1002/acr.23712. [Epub ahead of print]

PMID:
30044551
23.

Baricitinib for systemic lupus erythematosus: a double-blind, randomised, placebo-controlled, phase 2 trial.

Wallace DJ, Furie RA, Tanaka Y, Kalunian KC, Mosca M, Petri MA, Dörner T, Cardiel MH, Bruce IN, Gomez E, Carmack T, DeLozier AM, Janes JM, Linnik MD, de Bono S, Silk ME, Hoffman RW.

Lancet. 2018 Jul 21;392(10143):222-231. doi: 10.1016/S0140-6736(18)31363-1. Erratum in: Lancet. 2018 Aug 11;392(10146):476.

PMID:
30043749
24.

Preconceptional Cardiovascular Health and Pregnancy Outcomes in Women with Systemic Lupus Erythematosus.

Eudy AM, Siega-Riz AM, Engel SM, Franceschini N, Howard AG, Clowse MEB, Petri M.

J Rheumatol. 2019 Jan;46(1):70-77. doi: 10.3899/jrheum.171066. Epub 2018 Jul 15.

PMID:
30008449
25.

Hydroxychloroquine prescription trends and predictors for excess dosing per recent ophthalmology guidelines.

Jorge AM, Melles RB, Zhang Y, Lu N, Rai SK, Young LH, Costenbader KH, Ramsey-Goldman R, Lim SS, Esdaile JM, Clarke AE, Urowitz MB, Askanase A, Aranow C, Petri M, Choi H.

Arthritis Res Ther. 2018 Jul 5;20(1):133. doi: 10.1186/s13075-018-1634-8.

26.

Stratification of Systemic Lupus Erythematosus Patients Into Three Groups of Disease Activity Progression According to Longitudinal Gene Expression.

Toro-Domínguez D, Martorell-Marugán J, Goldman D, Petri M, Carmona-Sáez P, Alarcón-Riquelme ME.

Arthritis Rheumatol. 2018 Dec;70(12):2025-2035. doi: 10.1002/art.40653. Epub 2018 Oct 27.

PMID:
29938934
27.

The effect of anti-inflammatory and antifibrotic agents on fibroblasts obtained from arthrofibrotic tissue: An in vitro and in vivo study.

Tang X, Teng S, Petri M, Krettek C, Liu C, Jagodzinski M.

Bone Joint Res. 2018 May 5;7(3):213-222. doi: 10.1302/2046-3758.73.BJR-2017-0219.R2. eCollection 2018 Mar.

28.

A plausibly causal functional lupus-associated risk variant in the STAT1-STAT4 locus.

Patel Z, Lu X, Miller D, Forney CR, Lee J, Lynch A, Schroeder C, Parks L, Magnusen AF, Chen X, Pujato M, Maddox A, Zoller EE, Namjou B, Brunner HI, Henrickson M, Huggins JL, Williams AH, Ziegler JT, Comeau ME, Marion MC, Glenn SB, Adler A, Shen N, Nath SK, Stevens AM, Freedman BI, Pons-Estel BA, Tsao BP, Jacob CO, Kamen DL, Brown EE, Gilkeson GS, Alarcón GS, Martin J, Reveille JD, Anaya JM, James JA, Sivils KL, Criswell LA, Vilá LM, Petri M, Scofield RH, Kimberly RP, Edberg JC, Ramsey-Goldman R, Bang SY, Lee HS, Bae SC, Boackle SA, Cunninghame Graham D, Vyse TJ, Merrill JT, Niewold TB, Ainsworth HC, Silverman ED, Weisman MH, Wallace DJ, Raj P, Guthridge JM, Gaffney PM, Kelly JA, Alarcón-Riquelme ME, Langefeld CD, Wakeland EK, Kaufman KM, Weirauch MT, Harley JB, Kottyan LC.

Hum Mol Genet. 2018 Apr 18. doi: 10.1093/hmg/ddy140. [Epub ahead of print]

PMID:
29912393
29.

Cerebral Venous Thrombosis Mimicking a Discrete Brain Mass: A Case Report and Literature Review.

DiRenzo D, McMahan ZH, Desai NS, Manno R, Petri M.

Case Rep Rheumatol. 2018 May 17;2018:5862912. doi: 10.1155/2018/5862912. eCollection 2018.

30.

The SLE-key test serological signature: new insights into the course of lupus.

Putterman C, Pisetsky DS, Petri M, Caricchio R, Wu AHB, Sanz I, Oates JC, Wallace S, Sorek R, Gerwien R, Safer P, Jakobi-Brook K, Cohen IR.

Rheumatology (Oxford). 2018 Sep 1;57(9):1632-1640. doi: 10.1093/rheumatology/key149.

PMID:
29873771
31.

Erythrocyte-bound C4d in combination with complement and autoantibody status for the monitoring of SLE.

Merrill JT, Petri MA, Buyon J, Ramsey-Goldman R, Kalunian K, Putterman C, Conklin J, Furie RA, Dervieux T.

Lupus Sci Med. 2018 May 23;5(1):e000263. doi: 10.1136/lupus-2018-000263. eCollection 2018.

32.

Comparison of Remission and Lupus Low Disease Activity State in Damage Prevention in a United States Systemic Lupus Erythematosus Cohort.

Petri M, Magder LS.

Arthritis Rheumatol. 2018 Nov;70(11):1790-1795. doi: 10.1002/art.40571.

PMID:
29806142
33.

Quantifying the burden of steroid-related damage in SLE in the Hopkins Lupus Cohort.

Davidson JE, Fu Q, Rao S, Magder LS, Petri M.

Lupus Sci Med. 2018 May 14;5(1):e000237. doi: 10.1136/lupus-2017-000237. eCollection 2018.

34.

Strong Neutron Pairing in core+4n Nuclei.

Revel A, Marqués FM, Sorlin O, Aumann T, Caesar C, Holl M, Panin V, Vandebrouck M, Wamers F, Alvarez-Pol H, Atar L, Avdeichikov V, Beceiro-Novo S, Bemmerer D, Benlliure J, Bertulani CA, Boillos JM, Boretzky K, Borge MJG, Caamaño M, Casarejos E, Catford WN, Cederkäll J, Chartier M, Chulkov L, Cortina-Gil D, Cravo E, Crespo R, Datta Pramanik U, Díaz Fernández P, Dillmann I, Elekes Z, Enders J, Ershova O, Estradé A, Farinon F, Fraile LM, Freer M, Galaviz D, Geissel H, Gernhäuser R, Golubev P, Göbel K, Hagdahl J, Heftrich T, Heil M, Heine M, Heinz A, Henriques A, Ignatov A, Johansson HT, Jonson B, Kahlbow J, Kalantar-Nayestanaki N, Kanungo R, Kelic-Heil A, Knyazev A, Kröll T, Kurz N, Labiche M, Langer C, Le Bleis T, Lemmon R, Lindberg S, Machado J, Marganiec J, Movsesyan A, Nacher E, Najafi M, Nilsson T, Nociforo C, Paschalis S, Perea A, Petri M, Pietri S, Plag R, Reifarth R, Ribeiro G, Rigollet C, Röder M, Rossi D, Savran D, Scheit H, Simon H, Syndikus I, Taylor JT, Tengblad O, Thies R, Togano Y, Velho P, Volkov V, Wagner A, Weick H, Wheldon C, Wilson G, Winfield JS, Woods P, Yakorev D, Zhukov M, Zilges A, Zuber K.

Phys Rev Lett. 2018 Apr 13;120(15):152504. doi: 10.1103/PhysRevLett.120.152504.

PMID:
29756867
35.

ERV1/ChemR23 Signaling Protects Against Atherosclerosis by Modifying Oxidized Low-Density Lipoprotein Uptake and Phagocytosis in Macrophages.

Laguna-Fernandez A, Checa A, Carracedo M, Artiach G, Petri MH, Baumgartner R, Forteza MJ, Jiang X, Andonova T, Walker ME, Dalli J, Arnardottir H, Gisterå A, Thul S, Wheelock CE, Paulsson-Berne G, Ketelhuth DFJ, Hansson GK, Bäck M.

Circulation. 2018 Oct 16;138(16):1693-1705. doi: 10.1161/CIRCULATIONAHA.117.032801.

36.

The Impact of Systemic Lupus Erythematosus on the Clinical Phenotype of Antiphospholipid Antibody-Positive Patients: Results From the AntiPhospholipid Syndrome Alliance for Clinical Trials and InternatiOnal Clinical Database and Repository.

Unlu O, Erkan D, Barbhaiya M, Andrade D, Nascimento I, Rosa R, Banzato A, Pengo V, Ugarte A, Gerosa M, Ji L, Efthymiou M, Branch DW, de Jesus GR, Tincani A, Belmont HM, Fortin PR, Petri M, Rodriguez E, Pons-Estel GJ, Knight JS, Atsumi T, Willis R, Zuily S, Tektonidou MG; AntiPhospholipid Syndrome Alliance for Clinical Trials and InternatiOnal Networking Investigators.

Arthritis Care Res (Hoboken). 2019 Jan;71(1):134-141. doi: 10.1002/acr.23584.

PMID:
29669399
37.

In vivo heterotopic culturing of prefabricated tendon grafts with mechanical stimulation in a sheep model.

Petri M, Lu P, Omar M, Ettinger M, Krettek C, Neunaber C, Jagodzinski M.

Knee. 2018 Jun;25(3):381-391. doi: 10.1016/j.knee.2018.02.006. Epub 2018 Apr 11.

PMID:
29655901
38.

Response to: 'Postpartum breastfeeding status' by Betzold.

Eudy AM, Siega-Riz AM, Engel SM, Franceschini N, Howard AG, Clowse MEB, Petri M.

Ann Rheum Dis. 2018 Apr 11. pii: annrheumdis-2018-213427. doi: 10.1136/annrheumdis-2018-213427. [Epub ahead of print] No abstract available.

PMID:
29643109
39.

Overall Downregulation of mRNAs and Enrichment of H3K4me3 Change Near Genome-Wide Association Study Signals in Systemic Lupus Erythematosus: Cell-Specific Effects.

Zhang Z, Shi L, Song L, Maurer K, Petri MA, Sullivan KE.

Front Immunol. 2018 Mar 13;9:497. doi: 10.3389/fimmu.2018.00497. eCollection 2018.

40.

Performance Evaluation and Clinical Associations of Immunoassays That Detect Antibodies to Negatively Charged Phospholipids Other Than Cardiolipin.

Castanon A, Pierre G, Willis R, Harris EN, Papalardo E, Romay-Penabad Z, Schleh A, Jajoria P, Smikle M, DeCeulaer K, Tebo A, Jaskowski T, Guerra MM, Branch DW, Salmon JE, Petri M, Gonzalez EB.

Am J Clin Pathol. 2018 Mar 29;149(5):401-411. doi: 10.1093/ajcp/aqy003.

PMID:
29547897
41.

Higher sensitivity of swab polymerase chain reaction compared with tissue cultures for diagnosing periprosthetic joint infection.

Omar M, Petri M, Hawi N, Krettek C, Eberhard J, Liodakis E.

J Orthop Surg (Hong Kong). 2018 Jan-Apr;26(1):2309499018765296. doi: 10.1177/2309499018765296.

PMID:
29540099
42.

Renal Remission Status and Longterm Renal Survival in Patients with Lupus Nephritis: A Retrospective Cohort Analysis.

Davidson JE, Fu Q, Ji B, Rao S, Roth D, Magder LS, Petri M.

J Rheumatol. 2018 May;45(5):671-677. doi: 10.3899/jrheum.161554. Epub 2018 Mar 1.

43.

Autoimmune reactivity to malondialdehyde adducts in systemic lupus erythematosus is associated with disease activity and nephritis.

Hardt U, Larsson A, Gunnarsson I, Clancy RM, Petri M, Buyon JP, Silverman GJ, Svenungsson E, Grönwall C.

Arthritis Res Ther. 2018 Feb 26;20(1):36. doi: 10.1186/s13075-018-1530-2.

44.

Quasifree (p, 2p) Reactions on Oxygen Isotopes: Observation of Isospin Independence of the Reduced Single-Particle Strength.

Atar L, Paschalis S, Barbieri C, Bertulani CA, Díaz Fernández P, Holl M, Najafi MA, Panin V, Alvarez-Pol H, Aumann T, Avdeichikov V, Beceiro-Novo S, Bemmerer D, Benlliure J, Boillos JM, Boretzky K, Borge MJG, Caamaño M, Caesar C, Casarejos E, Catford W, Cederkall J, Chartier M, Chulkov L, Cortina-Gil D, Cravo E, Crespo R, Dillmann I, Elekes Z, Enders J, Ershova O, Estrade A, Farinon F, Fraile LM, Freer M, Galaviz Redondo D, Geissel H, Gernhäuser R, Golubev P, Göbel K, Hagdahl J, Heftrich T, Heil M, Heine M, Heinz A, Henriques A, Hufnagel A, Ignatov A, Johansson HT, Jonson B, Kahlbow J, Kalantar-Nayestanaki N, Kanungo R, Kelic-Heil A, Knyazev A, Kröll T, Kurz N, Labiche M, Langer C, Le Bleis T, Lemmon R, Lindberg S, Machado J, Marganiec-Gałązka J, Movsesyan A, Nacher E, Nikolskii EY, Nilsson T, Nociforo C, Perea A, Petri M, Pietri S, Plag R, Reifarth R, Ribeiro G, Rigollet C, Rossi DM, Röder M, Savran D, Scheit H, Simon H, Sorlin O, Syndikus I, Taylor JT, Tengblad O, Thies R, Togano Y, Vandebrouck M, Velho P, Volkov V, Wagner A, Wamers F, Weick H, Wheldon C, Wilson GL, Winfield JS, Woods P, Yakorev D, Zhukov M, Zilges A, Zuber K; R^{3}B Collaboration.

Phys Rev Lett. 2018 Feb 2;120(5):052501. doi: 10.1103/PhysRevLett.120.052501.

PMID:
29481189
45.

Effect of pregnancy on disease flares in patients with systemic lupus erythematosus.

Eudy AM, Siega-Riz AM, Engel SM, Franceschini N, Howard AG, Clowse MEB, Petri M.

Ann Rheum Dis. 2018 Jun;77(6):855-860. doi: 10.1136/annrheumdis-2017-212535. Epub 2018 Feb 20.

PMID:
29463519
46.
47.

Complement activation predicts adverse pregnancy outcome in patients with systemic lupus erythematosus and/or antiphospholipid antibodies.

Kim MY, Guerra MM, Kaplowitz E, Laskin CA, Petri M, Branch DW, Lockshin MD, Sammaritano LR, Merrill JT, Porter TF, Sawitzke A, Lynch AM, Buyon JP, Salmon JE.

Ann Rheum Dis. 2018 Apr;77(4):549-555. doi: 10.1136/annrheumdis-2017-212224. Epub 2018 Jan 25.

PMID:
29371202
48.

Glucocorticoid use and factors associated with variability in this use in the Systemic Lupus International Collaborating Clinics Inception Cohort.

Little J, Parker B, Lunt M, Hanly JG, Urowitz MB, Clarke AE, Romero-Diaz J, Gordon C, Bae SC, Bernatsky S, Wallace DJ, Merrill JT, Buyon J, Isenberg DA, Rahman A, Ginzler EM, Petri M, Dooley MA, Fortin P, Gladman DD, Steinsson K, Ramsey-Goldman R, Khamashta MA, Aranow C, Mackay M, Alarcón GS, Manzi S, Nived O, Jönsen A, Zoma AA, van Vollenhoven RF, Ramos-Casals M, Ruiz-Irastorza G, Sam Lim S, Kalunian KC, Inanc M, Kamen DL, Peschken CA, Jacobsen S, Askanase A, Sanchez-Guerrero J, Bruce IN.

Rheumatology (Oxford). 2018 Apr 1;57(4):677-687. doi: 10.1093/rheumatology/kex444.

PMID:
29361147
49.

Smoking Is the Most Significant Modifiable Lung Cancer Risk Factor in Systemic Lupus Erythematosus.

Bernatsky S, Ramsey-Goldman R, Petri M, Urowitz MB, Gladman DD, Fortin PR, Yelin EH, Ginzler E, Hanly JG, Peschken C, Gordon C, Nived O, Aranow C, Bae SC, Isenberg D, Rahman A, Hansen JE, Pierre YS, Clarke AE.

J Rheumatol. 2018 Mar;45(3):393-396. doi: 10.3899/jrheum.170652. Epub 2018 Jan 15.

PMID:
29335347
50.

Cerebrovascular Events in Systemic Lupus Erythematosus: Results From an International Inception Cohort Study.

Hanly JG, Li Q, Su L, Urowitz MB, Gordon C, Bae SC, Romero-Diaz J, Sanchez-Guerrero J, Bernatsky S, Clarke AE, Wallace DJ, Isenberg DA, Rahman A, Merrill JT, Fortin P, Gladman DD, Bruce IN, Petri M, Ginzler EM, Dooley MA, Steinsson K, Ramsey-Goldman R, Zoma AA, Manzi S, Nived O, Jonsen A, Khamashta MA, Alarcón GS, Chatham W, van Vollenhoven RF, Aranow C, Mackay M, Ruiz-Irastorza G, Ramos-Casals M, Lim SS, Inanc M, Kalunian KC, Jacobsen S, Peschken CA, Kamen DL, Askanase A, Theriault C, Farewell V.

Arthritis Care Res (Hoboken). 2018 Oct;70(10):1478-1487. doi: 10.1002/acr.23509. Epub 2018 Sep 1.

PMID:
29316357

Supplemental Content

Support Center